These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6412828)

  • 1. Renal handling of calcium in hypoparathyroidism.
    Newman GH; Wade M; Hosking DJ
    Br Med J (Clin Res Ed); 1983 Sep; 287(6395):781-4. PubMed ID: 6412828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bendrofluazide on calcium reabsorption in hypoparathyroidism.
    Newman GH; Wade M; Hosking DJ
    Eur J Clin Pharmacol; 1984; 27(1):41-6. PubMed ID: 6489426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Update on recent progress in vitamin D research. Vitamin D treatment for hypoparathyroidism.].
    Minagawa M
    Clin Calcium; 2017; 27(11):1623-1628. PubMed ID: 29074836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tubular maximum for calcium reabsorption: normal range and correction for sodium excretion.
    Need AG; Guerin MD; Pain RW; Hartley TF; Nordin BE
    Clin Chim Acta; 1985 Aug; 150(2):87-93. PubMed ID: 4042367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of urinary sodium excretion on the clinical assessment of renal tubular calcium reabsorption in hypercalcaemic man.
    Ralston SH; Gardner MD; Dryburgh FJ; Cowan RA; Boyle IT
    J Clin Pathol; 1986 Jun; 39(6):641-6. PubMed ID: 3722417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rehydration in the treatment of severe hypercalcaemia.
    Hosking DJ; Cowley A; Bucknall CA
    Q J Med; 1981; 50(200):473-81. PubMed ID: 7342172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-dihydroxycholecalciferol in hypoparathyroidism.
    Davies M; Taylor CM; Hill LF; Stanbury SW
    Lancet; 1977 Jan; 1(8002):55-9. PubMed ID: 63708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D.
    Arlt W; Fremerey C; Callies F; Reincke M; Schneider P; Timmermann W; Allolio B
    Eur J Endocrinol; 2002 Feb; 146(2):215-22. PubMed ID: 11834431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tubular maximum for calcium reabsorption in patients with chronic active thoracic sarcoidosis.
    Broulik PD; Votava V; Pacovsky V
    Eur Respir J; 1990 Apr; 3(4):447-9. PubMed ID: 2365038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional Treatment of Hypoparathyroidism.
    Babey M; Brandi ML; Shoback D
    Endocrinol Metab Clin North Am; 2018 Dec; 47(4):889-900. PubMed ID: 30390820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoparathyroidism.
    Al-Azem H; Khan AA
    Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):517-22. PubMed ID: 22863393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endogenous and exogenous parathyroid hormone on tubular reabsorption of calcium in pseudohypoparathyroidism.
    Yamamoto M; Takuwa Y; Masuko S; Ogata E
    J Clin Endocrinol Metab; 1988 Mar; 66(3):618-25. PubMed ID: 2832440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
    Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interactions of thiazide diuretics with parathyroid hormone and vitamin D. Studies in patients with hypoparathyroidism.
    Parfitt AM
    J Clin Invest; 1972 Jul; 51(7):1879-88. PubMed ID: 4338123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal tubular maximum for magnesium in normal, hyperparathyroid, and hypoparathyroid man.
    Rude RK; Bethune JE; Singer FR
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1425-31. PubMed ID: 7440705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypoparathyroidism with 1,25-dihydroxycholecalciferol.
    Hill LF; Davies M; Taylor CM; Standbury SW
    Clin Endocrinol (Oxf); 1976; 5 Suppl():167S-173S. PubMed ID: 1052776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hydrochlorothiazide upon serum and urinary calcium in patients with hypoparathyroidism.
    Arata RO; Mautalen CA; Geffner D; Horwith M
    Medicina (B Aires); 1974; 34(5):463-70. PubMed ID: 4437384
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypoparathyroidism and pseudohypoparathyroidism: etiology, laboratory features and complications.
    Lopes MP; Kliemann BS; Bini IB; Kulchetscki R; Borsani V; Savi L; Borba VZ; Moreira CA
    Arch Endocrinol Metab; 2016; 60(6):532-536. PubMed ID: 27901178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hypoparathyroidism by active vitamin D].
    Kaji H
    Clin Calcium; 2007 Aug; 17(8):1249-54. PubMed ID: 17660623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.